Not an eMediNexus Member?
The U.S. Food and Drug Administration has approved VESIcare LS (solifenacin succinate) oral suspension for the treatment of neur ...MORE
Getting rid of routine bladder catheterization improved outcomes for people undergoing atrial fibrillation (Afib) ablation, a single-center randomized trial ...MORE
Patients taking mirabegron (Myrbetriq) for overactive bladder (OAB) did not have an increased risk of cardiovascular (CV) events ...MORE
The US Food and Drug Administration (FDA) has granted accelerated approval to Balversa (erdafitinib), a treatment for adult pati ...MORE
Findings of a survey of Italian nurses and medical residents younger than 50 years presented March 17, 2019 at the European ...MORE
Once-daily plazomicin was noninferior to meropenem for the treatment of complicated UTIs and acute pyelonephritis caused by Ente ...MORE